A detailed history of Ing Groep Nv transactions in Pfizer Inc stock. As of the latest transaction made, Ing Groep Nv holds 681,827 shares of PFE stock, worth $18.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
681,827
Previous 1,254,572 45.65%
Holding current value
$18.2 Million
Previous $35.1 Million 43.79%
% of portfolio
0.12%
Previous 0.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$27.7 - $31.39 $15.9 Million - $18 Million
-572,745 Reduced 45.65%
681,827 $19.7 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $11.6 Million - $13.6 Million
460,286 Added 57.95%
1,254,572 $35.1 Million
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $6.57 Million - $7.54 Million
-253,662 Reduced 24.21%
794,286 $22 Million
Q4 2023

Feb 08, 2024

BUY
$26.13 - $33.94 $1.56 Million - $2.03 Million
59,719 Added 6.04%
1,047,948 $30.2 Million
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $14.1 Million - $16.5 Million
-440,695 Reduced 30.84%
988,229 $32.8 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $24.8 Million - $28.6 Million
-685,302 Reduced 32.41%
1,428,924 $52.4 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $21.8 Million - $28.3 Million
552,478 Added 35.38%
2,114,226 $86.3 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $27 Million - $35.3 Million
647,900 Added 70.9%
1,561,748 $80.1 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $4.8 Million - $5.86 Million
-109,673 Reduced 10.72%
913,848 $40 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $4.71 Million - $5.58 Million
101,119 Added 10.96%
1,023,521 $53.7 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $9.01 Million - $11.2 Million
196,987 Added 27.16%
922,402 $47.8 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $10.6 Million - $15.7 Million
256,273 Added 54.63%
725,415 $42.8 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $119,987 - $154,133
-3,057 Reduced 0.65%
469,142 $20.2 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $3.45 Million - $3.91 Million
96,055 Added 25.54%
472,199 $18.5 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $4,822 - $5,438
144 Added 0.04%
376,144 $13.6 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $5.08 Million - $6.45 Million
151,645 Added 67.59%
376,000 $13.8 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $1.83 Million - $2.15 Million
57,757 Added 34.67%
224,355 $8.23 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $4.52 Million - $5.48 Million
-150,005 Reduced 47.38%
166,598 $5.45 Million
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $7.4 Million - $10.6 Million
-273,856 Reduced 46.38%
316,603 $10.3 Million
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $4.1 Million - $4.65 Million
-124,480 Reduced 17.41%
590,459 $23.1 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $20.3 Million - $26.3 Million
-625,279 Reduced 46.66%
714,939 $25.7 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $34.8 Million - $39 Million
939,842 Added 234.74%
1,340,218 $58.1 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $17.8 Million - $19.6 Million
-475,002 Reduced 54.26%
400,376 $17 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $9.33 Million - $10.6 Million
-242,578 Reduced 21.7%
875,378 $38.2 Million
Q3 2018

Nov 06, 2018

SELL
$34.47 - $41.81 $470,446 - $570,622
-13,648 Reduced 1.21%
1,117,956 $49.3 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $23.4 Million - $24.9 Million
708,742 Added 167.61%
1,131,604 $41.1 Million
Q1 2018

May 07, 2018

SELL
$31.91 - $37.02 $21 Million - $24.4 Million
-658,515 Reduced 60.9%
422,862 $15 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $32.6 Million - $34.6 Million
-980,370 Reduced 47.55%
1,081,377 $39.2 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $63.9 Million - $70.4 Million
2,061,747
2,061,747 $73.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.